NDA/BLA filedconf 0.95
olutasidenib — NDA/BLA filed
$RIGL · RIGEL PHARMACEUTICALS INC · relapsed/refractory acute myeloid leukemia (R/R AML)
Event date
Date TBD
Sponsor runway
cash-flow +
$146.7M liquid
Evidence
Comparable historical nda/bla fileds· last 5 years · same event type
| Ticker | Drug | Date | Outcome |
|---|---|---|---|
| $AXSM | — | 2025-12-31 | unknown |
| $RCKT | kresladi | 2025-10-14 | unknown |
| $ALDX | reproxalap | 2025-07-17 | unknown |
| $ETON | et-600 | 2025-07-08 | unknown |
| $BCRX | orladeyo (berotralstat) | 2025-05-14 | unknown |
| $CORT | relacorilant | 2025-03-03 | unknown |
| $ALDX | reproxalap | 2024-11-01 | unknown |
| $AXSM | axs-07 | 2024-09-04 | unknown |
| $RCKT | kresladi | 2023-10-02 | unknown |
| $GERN | imetelstat | 2023-08-21 | unknown |
Recent insider activity· ±90 days
7 insiders · 0 buys · 0 sells
Grant
2026-05-15Wasman Jane
Director
5,750 @ ——
Grant
2026-05-15MILLER MICHAEL PATRICK
Director
5,750 @ ——
Grant
2026-05-15HANNAH ALISON L.
Director
5,750 @ ——
Grant
2026-05-15Ali-Jackson Kamil
Director
5,750 @ ——
Grant
2026-05-15LAPOINTE ANTHONY GREGG
Director
5,750 @ ——
Grant
2026-05-15Frohlich Mark W
Director
5,750 @ ——
Grant
2026-05-15MOOS WALTER H
Director
5,750 @ ——